GEVO:NSC-Gevo Inc. (USD)

EQUITY | Specialty Chemicals | NASDAQ Capital Market

Last Closing

USD 0.6905

Change

-0.01 (-1.85)%

Market Cap

USD 0.04B

Volume

2.06M

Analyst Target

USD 3.52
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Gevo Inc is a renewable chemicals and biofuels company. It is engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
LIN Linde plc Ordinary Shares

-2.85 (-0.65%)

USD 208.56B
BCPC Balchem Corporation

-1.62 (-1.06%)

USD 4.97B
IOSP Innospec Inc

-2.62 (-2.09%)

USD 3.15B
WDFC WD-40 Company

-1.11 (-0.50%)

USD 3.07B
HWKN Hawkins Inc

-0.52 (-0.60%)

USD 1.81B
HDSN Hudson Technologies Inc

-0.24 (-2.56%)

USD 0.41B
LWLG Lightwave Logic Inc

+0.09 (+2.63%)

USD 0.37B
NTIC Northern Technologies

-0.15 (-0.85%)

USD 0.17B
LOOP Loop Industries Inc

-0.05 (-1.83%)

USD 0.12B
ALTO Alto Ingredients Inc

-0.02 (-1.47%)

USD 0.10B

ETFs Containing GEVO

DKRB 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (NASDAQ Capital Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -40.47% 22% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -40.47% 22% F 13% F
Trailing 12 Months  
Capital Gain -44.31% 31% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -44.31% 31% F 21% F
Trailing 5 Years  
Capital Gain -64.59% 18% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -64.59% 18% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain 174.08% 93% A 97% N/A
Dividend Return 174.08% 93% A 97% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1,159.54% 7% C- 2% F
Risk Adjusted Return 15.01% 53% F 52% F
Market Capitalization 0.04B 56% F 46% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (NASDAQ Capital Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 0.30 83% 95%
Price/Book Ratio 0.27 94% 96%
Price / Cash Flow Ratio -3.21 81% 71%
Price/Free Cash Flow Ratio 1.68 56% 40%
Management Effectiveness  
Return on Equity -11.89% 44% 49%
Return on Invested Capital -13.29% 44% 37%
Return on Assets -7.95% 44% 37%
Debt to Equity Ratio 0.00% 100% 88%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector